HIGHLIGHTS
- who: Biochemical Society Transactions and collaborators from the Department University of Melbourne, Melbourne, VIC, Australia have published the paper: Last but not least: BFL-1 as an emerging target for anti-cancer therapies, in the Journal: (JOURNAL) of 28/07/2022
- what: With each new vulnerability of cancer targeted and exploited, it seems that new complications emerge.
SUMMARY
BFL-1 and A1 discovery and function Due to its homology to other BCL-2 family genes, and its overexpression in clinical samples of stomach cancer, BFL-1 was hypothesised to promote cell . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.